Iatrogenic Creutzfeldt–Jakob disease in Australia: time to amend infection control measures for pituitary hormone recipients?

Solvyns, Suzanne L; Ralston, David W

doi:10.5694/j.1326-5377.2011.tb03793.x

Topics

To the Editor: Although we welcome Boyd and colleagues’ recommendations for changes to infection control guidelines for Australian recipients of human growth hormone (hGH) and human pituitary gonadotrophin (hPG),1 we are concerned about the accuracy of the history provided and do not want it misrepresented.

CJD Support Group Network, Sydney, NSW.

Correspondence: s.solvyns@cjdsupport.org.au

1. Boyd A, Klug GMJA, Schonberger LB, et al. Iatrogenic Creutzfeldt–Jakob disease in Australia: time to amend infection control measures for pituitary hormone recipients? Med J Aust 2010; 193: 366-369. <eMJA full text> <MJA full text>
2. Allars M. Report of the inquiry into the use of pituitary derived hormones in Australia and Creutzfeldt-Jakob disease. Canberra: AGPS, 1994.
3. Cooke J. Cannibals, cows and the CJD catastrophe. Sydney: Random House Australia, 1998: 224.

Online responses are no longer available. Please refer to our instructions for authors page for more information.